Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City

被引:14
|
作者
Park, Bo Eun [1 ]
Lee, Jang Hoon [1 ,2 ]
Park, Hyuk Kyoon [1 ]
Kim, Hong Nyun [1 ]
Jang, Se Yong [1 ,2 ]
Bae, Myung Hwan [1 ,2 ]
Yang, Dong Heon [1 ,2 ]
Park, Hun Sik [1 ,2 ]
Cho, Yongkeun [1 ,2 ]
Lee, Bong Yul [3 ]
Nam, Chang Wook [4 ]
Lee, Jin Bae [5 ]
Kim, Ung [6 ]
Chae, Shung Chull [1 ,2 ]
机构
[1] Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea
[2] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea
[3] Daegu Fatima Hosp, Dept Internal Med, Daegu, South Korea
[4] Keimyung Univ, Dept Internal Med, Dongsan Med Ctr, Daegu, South Korea
[5] Daegu Catholic Univ Hosp, Dept Internal Med, Daegu, South Korea
[6] Yeungnam Univ Hosp, Dept Internal Med, Daegu, South Korea
关键词
Coronavirus; SARS-CoV-2; COVID-19; Cardiovascular Risk Factors; Cardiovascular Disease; Prognosis; CLINICAL CHARACTERISTICS;
D O I
10.3346/jkms.2021.36.e15
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Data regarding the association between preexisting cardiovascular risk factors (CVRFs) and cardiovascular diseases (CVDs) and the outcomes of patients requiring hospitalization for coronavirus disease 2019 (COVID-19) are limited. Therefore, the aim of this study was to investigate the impact of preexisting CVRFs or CVDs on the outcomes of patients with COVID-19 hospitalized in a Korean healthcare system. Methods: Patients with COVID-19 admitted to 10 hospitals in Daegu Metropolitan City, Korea, were examined. All sequentially hospitalized patients between February 15, 2020, and April 24, 2020, were enrolled in this study. All patients were confirmed to have COVID-19 based on the positive results on the polymerase chain reaction testing of nasopharyngeal samples. Clinical outcomes during hospitalization, such as requiring intensive care and invasive mechanical ventilation (MV) and death, were evaluated. Moreover, data on baseline comorbidities such as a history of diabetes, hypertension, dyslipidemia, current smoking, heart failure, coronary artery disease, cerebrovascular accidents, and other chronic cardiac diseases were obtained. Results: Of all the patients enrolled, 954 (42.0%) had preexisting CVRFs or CVDs. Among the CVRFs, the most common were hypertension (28.8%) and diabetes mellitus (17.0%). The prevalence rates of preexisting CVRF5 or CVDs increased with age (P < 0.001). The number of patients requiring intensive care (P< 0.001) and invasive MV (P< 0.001) increased with age. The in-hospital death rate increased with age (P< 0.001). Patients requiring intensive care (5.3% vs. 1.6%; P< 0.001) and invasive MV (4.3% vs. 1.7%; P< 0.001) were significantly greater in patients with preexisting CVRF5 or CVDs. In-hospital mortality (12.9% vs. 3.1%; P< 0.001) was significantly higher in patients with preexisting CVRFs or CVDs. Among the CVRFs, diabetes mellitus and hypertension were associated with increased requirement of intensive care and invasive MV and in-hospital death. Among the known CVDs, coronary artery disease and congestive heart failure were associated with invasive MV and in-hospital death. In multivariate analysis, preexisting CVRFs or CVDs (odds ratio [OR], 1.79; 95% confidence interval [CI], 1.07-3.01; P= 0.027) were independent predictors of in-hospital death after adjusting for confounding variables. Among individual preexisting CVRF or CVll components, diabetes mellitus (OR, 2.43; 95% CI, 1.51-3.90; P< 0.001) and congestive heart failure (OR, 2.43; 95% CI, 1.06-5.87; P= 0.049) were independent predictors of in-hospital death. Conclusion: Based on the findings of this study, the patients with confirmed COVID-19 with preexisting CVRFs or CVDs had worse clinical outcomes. Caution is required in dealing with these patients at triage.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City
    Siniorakis, Eftychios
    Arvanitakis, Spyridon
    Katsianis, Antonios
    Nikolopoulos, Ioannis
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (15)
  • [3] Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients
    Xu, Qian
    Samanapally, Harideep
    Nathala, Pavani
    Salunkhe, Vidyulata
    Furmanek, Stephen
    Cahill, Meredith N.
    McGuffin, Trevor
    Mohammad, Tahboub
    Marsili, Bradford
    Petrey, Jessica
    Carrico, Ruth
    Ramirez, Julio
    Akca, Ozan
    Clifford, Sean P.
    Pahwa, Siddharth
    Roser, Lynn
    Kong, Maiying
    Huang, Jiapeng
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (12) : 3581 - 3593
  • [4] Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients
    Huang, Jiapeng
    Xu, Qian
    Samanapally, Harideep
    Nathala, Pavani
    Salunkhe, Vidyulata
    Roser, Lynn
    Kong, Maiying
    [J]. ANESTHESIA AND ANALGESIA, 2021, 132 (5S_SUPPL): : 135 - 141
  • [5] Cardiovascular risk factors and clinical outcomes of patients hospitalized with COVID-19 pneumonia in Somalia
    Ahmed, Mohammed A. M.
    Hussein, Ahmed Mohamud
    Abdullahi, Aweis Ahmed Moalim
    Ahmed, Abdirizak Yusuf
    Hussain, Hamdi M. A.
    Ali, Abdiaziz Mohamed
    Barre, Abdulqadir Abdinur
    Yusuf, Farhia Mohamud
    Olum, Ronald
    Sereke, Senai Goitom
    Elfadul, Maisa Ahmed
    Colebunders, Robert
    Bongomin, Felix
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
  • [6] Cardiovascular risk factors and clinical outcomes of patients hospitalized with COVID-19 pneumonia in Somalia
    Ahmed, Mohammed A. M.
    Hussein, Ahmed Mohamud
    Abdullahi, Aweis Ahmed Moalim
    Ahmed, Abdirizak Yusuf
    Hussain, Hamdi M. A.
    Ali, Abdiaziz Mohamed
    Barre, Abdulqadir Abdinur
    Yusuf, Farhia Mohamud
    Olum, Ronald
    Sereke, Senai Goitom
    Elfadul, Maisa Ahmed
    Colebunders, Robert
    Bongomin, Felix
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
  • [7] Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients
    Jewbali, L. S. D.
    Hoogervorst-Schilp, J.
    Belfroid, E.
    Jansen, C. W.
    Asselbergs, F. W.
    Siebelink, H. J.
    [J]. NETHERLANDS HEART JOURNAL, 2021, 29 (SUPPL 1) : 13 - 19
  • [8] Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients
    L. S. D. Jewbali
    J. Hoogervorst-Schilp
    E. Belfroid
    C. W. Jansen
    F. W. Asselbergs
    H. J. Siebelink
    [J]. Netherlands Heart Journal, 2021, 29 : 13 - 19
  • [9] Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
    Saito, Takafumi
    Yamaguchi, Tetsuo
    Kuroda, Shunsuke
    Kitai, Takeshi
    Yonetsu, Taishi
    Kohsaka, Shun
    Torii, Sho
    Node, Koichi
    Matsumoto, Shingo
    Matsue, Yuya
    Kodama, Takahide
    [J]. JOURNAL OF CARDIOLOGY, 2022, 79 (04) : 476 - 481
  • [10] ROLE OF HYPERTENSION, CARDIOVASCULAR DISEASE AND CARDIOVASCULAR RISK FACTORS ON OUTCOME IN HOSPITALIZED COVID-19 PATIENTS
    Chiarini, Giulia
    Boari, Gianluca E. M.
    Bonetti, Silvia
    Orlandini, Federico Braglia
    Malerba, Paolo
    Bianco, Gianluca
    Faustini, Cristina
    Rizzoni, Damiano
    [J]. JOURNAL OF HYPERTENSION, 2021, 39 : E205 - E205